$9.45 Billion is the total value of Bellevue Group AG's 260 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RDUS | RADIUS HEALTH INC | $157,105,000 | +16.8% | 7,531,414 | 0.0% | 1.66% | +7.9% | |
| ITCI | INTRA CELLULAR THERAPIES INC | $124,181,000 | +6.7% | 3,659,919 | 0.0% | 1.31% | -1.4% | |
| EXEL | EXELIXIS INC | $66,517,000 | +12.6% | 2,944,500 | 0.0% | 0.70% | +4.0% | |
| BAX | BAXTER INTL INC | $40,030,000 | +5.1% | 474,623 | 0.0% | 0.42% | -2.8% | |
| KZR | KEZAR LIFE SCIENCES INC | $27,018,000 | +14.2% | 4,533,148 | 0.0% | 0.29% | +5.5% | |
| FIXX | HOMOLOGY MEDICINES INC | $16,346,000 | -16.7% | 1,737,122 | 0.0% | 0.17% | -23.1% | |
| AVTR | AVANTOR INC | $14,818,000 | +2.8% | 512,216 | 0.0% | 0.16% | -4.8% | |
| WVE | WAVE LIFE SCIENCES LTD | $14,602,000 | -28.7% | 2,602,858 | 0.0% | 0.15% | -34.5% | |
| XRAY | DENTSPLY SIRONA INC | $10,154,000 | +21.9% | 159,129 | 0.0% | 0.11% | +12.6% | |
| LUNG | PULMONX CORP | $8,074,000 | -33.7% | 176,510 | 0.0% | 0.08% | -39.3% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $4,668,000 | -17.8% | 41,000 | 0.0% | 0.05% | -24.6% | |
| ALLK | ALLAKOS INC | $2,123,000 | -18.0% | 18,500 | 0.0% | 0.02% | -26.7% | |
| APLS | APELLIS PHARMACEUTICALS INC | $2,060,000 | -25.0% | 48,000 | 0.0% | 0.02% | -29.0% | |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $1,998,000 | -22.7% | 15,500 | 0.0% | 0.02% | -30.0% | |
| CLLS | CELLECTIS S Aspon ads | $1,688,000 | -25.3% | 83,500 | 0.0% | 0.02% | -30.8% | |
| DRNA | DICERNA PHARMACEUTICALS INC | $1,739,000 | +16.1% | 68,000 | 0.0% | 0.02% | +5.9% | |
| KURA | KURA ONCOLOGY INC | $1,640,000 | -13.4% | 58,000 | 0.0% | 0.02% | -22.7% | |
| SRPT | SAREPTA THERAPEUTICS INC | $1,513,000 | -56.3% | 20,300 | 0.0% | 0.02% | -60.0% | |
| QURE | UNIQURE NV | $1,162,000 | -6.7% | 34,500 | 0.0% | 0.01% | -14.3% | |
| RDY | DR REDDYS LABS LTDadr | $522,000 | -13.9% | 8,500 | 0.0% | 0.01% | -14.3% | |
| MKL | MARKEL CORP | $456,000 | +10.4% | 400 | 0.0% | 0.01% | 0.0% | |
| MCK | MCKESSON CORP | $474,000 | +12.1% | 2,430 | 0.0% | 0.01% | 0.0% | |
| OPT | OPTHEA LTDsponsored ads | $483,000 | -15.0% | 50,000 | 0.0% | 0.01% | -28.6% | |
| DPZ | DOMINOS PIZZA INC | $368,000 | -3.9% | 1,000 | 0.0% | 0.00% | 0.0% | |
| CLX | CLOROX CO DEL | $386,000 | -4.5% | 2,000 | 0.0% | 0.00% | -20.0% | |
| SPGI | S&P GLOBAL INC | $423,000 | +7.4% | 1,200 | 0.0% | 0.00% | -20.0% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $185,000 | -6.6% | 8,000 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.